Giant cell arteritis - 3D vessel wall imaging with blood suppression using 3T MRI

Not Applicable

• Conditions: M31.6; Other giant cell arteritis

• Registration Number: DRKS00009518
• Lead Sponsor: euroradiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-10-13
• Study Completion: 2016-03-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 39

Inclusion Criteria

1. clinical indication for a MRI.
2. Patient is mature and of full age.
3. Exclusion of pregnancy through anamnesis or in cases of uncertainty through testing.

Exclusion Criteria

There is a contraindication versus a MRI examination.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
We want to prove if a new 3T sequence (T1 SPACE with fat- und blood suppression) is better showing the extracraniel vessels then the standard sequences.

Secondary Outcome Measures

Name	Time	Method
Comparison of the new and old sequences evaluating extracranial vessels.